Device type · QRF
Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QRF
Immunology
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
- Product code
- QRF
- Device class
- Class III
- Review panel
- Immunology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for QRF
Latest FDA decisions
- IsoPSA AssayBreakthroughPMA
P200048 · Decided Nov 28, 2025 · 1,796 days after receipt
Device type: Multi-analyte test system with algorithmic analysis for detection of prostate cancer (QRF) · Laboratory Medicine & Pathology
- 4Kscore TestPMA
P190022 · Decided Dec 7, 2021 · 823 days after receipt
Device type: Multi-analyte test system with algorithmic analysis for detection of prostate cancer (QRF) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0516-2024 · Started Oct 31, 2023 · Posted by FDA Dec 8, 2023
Reason given: Mathematical modeling of the 4Kscore with and without DRE information was recently performed on over 3,000 specimens. DRE information is a required component of The 4Kscore Test.
Cause as FDA categorized it: Device Design
Z-1676-2023 · Started Nov 18, 2022 · Posted by FDA Jun 2, 2023
Reason given: SPM software anomalies that may lead to the generation of erroneous 4Kscore Test results
Cause as FDA categorized it: Software Design Change
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.